Funding
Series E · Biotech

Circle Pharma raises $92.5M Series E led by The Column Group

Circle Pharma raised $92.5 million in Series E financing led by The Column Group in September.

Updated Oct 16, 2026By RoundOS Funding desk

RA Capital Management, Eli Lilly, Euclidean Capital and Nextech Invest also participated.

The company plans to expand operations and research and development as it advances its macrocycle therapeutic programs.

Use of funds

Expand operations and research and development

Funding history

Series E · This round$92.5M

Sources

  1. Circle Pharma Raises $92.5M in Series E Fundingfinsmes.com · Sep 16, 2026
  2. circlepharma.com
  3. circlepharma.com

Similar rounds

All Biotech rounds →
Star Therapeutics

Biotechnology company discovering and developing antibody therapies for diseases with significant unmet need.

$200MPrivate financing · Oct 23, 2026
Pathos AI

Clinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.

$237MSeries E · Oct 23, 2026
Warp Sciences

Warp Sciences combines chemistry, AI and robotics to help drug discovery teams make and test molecules in the United States.

$215MSeries A · Oct 22, 2026
SEGNOS

SEGNOS develops magnetic-particle materials and diagnostic technologies for blood testing.

UndisclosedPre-Series A · Oct 22, 2026

Related